Capricor Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update

Go back to Capricor Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update

Capricor Therapeutics (CAPR) Misses Q4 EPS by 2c

March 17, 2016 4:01 PM EDT

Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

... More